# ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

> **NCT00043576** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Novacea** · enrollment: 250 (—)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** calcitriol
- **DRUG:** docetaxel

## Key facts

- **NCT ID:** NCT00043576
- **Lead sponsor:** Novacea
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-08
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 250 (—)
- **Last updated:** 2009-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00043576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00043576, "ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00043576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*